×
About 3,488 results

ALLMedicine™ Dyspareunia Center

Research & Reviews  1,096 results

Esmya Versus Surgery Before IVF/ICSI
https://clinicaltrials.gov/ct2/show/NCT04028986

May 20th, 2022 - Uterine fibroids are the most common benign uterine tumors in women of reproductive age. Symptoms are depending on size, number and localisation of the fibroids. Heavy menstrual bleeding, anaemia, abdominal pain, dyspareunia and urinary symptoms a...

THE ASSOCIATION BETWEEN CHILDHOOD ADVERSITY AND RISK OF DYSMENORRHOEA, PELVIC PAIN AND ...
https://doi.org/10.1016/j.jpag.2022.04.010
Journal of Pediatric and Adolescent Gynecology; Moussaoui D, Grover SR

May 16th, 2022 - The exposure to adverse childhood experiences (ACEs) has been associated with poor health outcomes, including chronic pain. However, little is known about the potential impact on the development of pelvic pain in adolescents and young adults. This...

Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain
https://clinicaltrials.gov/ct2/show/NCT02173405

May 10th, 2022 - BACKGROUND AND RATIONALE: Chronic pelvic pain affects 15-20% of the female population aged 18-50 years and accounts for up to 10% of gynecologic visits each year resulting in a cost of 2.8 billion dollars annually to the health care system. It is ...

The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms
https://clinicaltrials.gov/ct2/show/NCT05367089

May 10th, 2022 - The purpose of this study is to investigate the vaginal culture (positive or negative) after the application of a Medical Grade Honey formulation (L-Mesitran ®) in relation to the current standard of care (Fluconazole) 1 month after starting treat...

Dyspareunia: Keys to biopsychosocial evaluation and treatment planning.
https://doi.org/10.12788/jfp.0365
The Journal of Family Practice; Williams AA

May 5th, 2022 - Asking the questions identified here can guide your care. Knowing which treatment options are-and aren't-supported by the evidence is also key.

see more →

Guidelines  8 results

Vaginitis in Nonpregnant Patients: ACOG Practice Bulletin Summary, Number 215.
https://doi.org/10.1097/AOG.0000000000003605
Obstetrics and Gynecology;

Dec 20th, 2019 - Vaginitis is defined as inflammation or infection of the vagina and is associated with a spectrum of symptoms, including vulvovaginal itching, burning, irritation, dyspareunia, "fishy" vaginal odor, and abnormal vaginal discharge. Vaginal symptoms...

Elective Female Genital Cosmetic Surgery: ACOG Committee Opinion Summary, Number 795.
https://doi.org/10.1097/AOG.0000000000003617
Obstetrics and Gynecology;

Dec 20th, 2019 - "Female genital cosmetic surgery" is a broad term that comprises numerous procedures, including labiaplasty, clitoral hood reduction, hymenoplasty, labia majora augmentation, vaginoplasty, and G-spot amplification. Both patient interest in and per...

Vaginitis in Nonpregnant Patients: ACOG Practice Bulletin, Number 215.
https://doi.org/10.1097/AOG.0000000000003604
Obstetrics and Gynecology;

Dec 20th, 2019 - Vaginitis is defined as inflammation or infection of the vagina and is associated with a spectrum of symptoms, including vulvovaginal itching, burning, irritation, dyspareunia, "fishy" vaginal odor, and abnormal vaginal discharge. Vaginal symptoms...

No. 279-Female Sexual Health Consensus Clinical Guidelines.
https://doi.org/10.1016/j.jogc.2018.04.009
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Lamont J, Bajzak K et. al.

Jun 5th, 2018 - To establish national guidelines for the assessment of women's sexual health concerns and the provision of sexual health care for women. Published literature was retrieved through searches of PubMed, CINAHL, and the Cochrane Library from May to Oc...

No. 351-Transvaginal Mesh Procedures for Pelvic Organ Prolapse.
https://doi.org/10.1016/j.jogc.2017.05.006
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Larouche M, Geoffrion R et. al.

Oct 31st, 2017 - This guideline reviews the evidence related to the risks and benefits of using transvaginal mesh in pelvic organ prolapse repairs in order to update recommendations initially made in 2011. Gynaecologists, residents, urologists, urogynaecologists, ...

see more →

Drugs  13 results see all →

Clinicaltrials.gov  68 results

Esmya Versus Surgery Before IVF/ICSI
https://clinicaltrials.gov/ct2/show/NCT04028986

May 20th, 2022 - Uterine fibroids are the most common benign uterine tumors in women of reproductive age. Symptoms are depending on size, number and localisation of the fibroids. Heavy menstrual bleeding, anaemia, abdominal pain, dyspareunia and urinary symptoms a...

Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain
https://clinicaltrials.gov/ct2/show/NCT02173405

May 10th, 2022 - BACKGROUND AND RATIONALE: Chronic pelvic pain affects 15-20% of the female population aged 18-50 years and accounts for up to 10% of gynecologic visits each year resulting in a cost of 2.8 billion dollars annually to the health care system. It is ...

The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms
https://clinicaltrials.gov/ct2/show/NCT05367089

May 10th, 2022 - The purpose of this study is to investigate the vaginal culture (positive or negative) after the application of a Medical Grade Honey formulation (L-Mesitran ®) in relation to the current standard of care (Fluconazole) 1 month after starting treat...

Mostafa Maged Four-stitch Technique in Closure the Episiotomy During Vaginal Delivery
https://clinicaltrials.gov/ct2/show/NCT05247073

Mar 29th, 2022 - Methodology: This technique will be applied to all women with episiotomy at the time of delivery or having tears in the perineum or the vagina. The technique uses absorbable vicryl threads with round needles 75 mm long. The technique includes the ...

Laser Treatment of Genito-urinary Syndrome in Women
https://clinicaltrials.gov/ct2/show/NCT03238053

Mar 16th, 2022 - Genitourinary syndrome of menopause (GSM) is characterized by symptoms such as vaginal dryness, dyspareunia, irritation, urinary incontinence, overactive bladder , and urinary tract infections. GSM replaces the previous term vulvovaginal atrophy a...

see more →

News  206 results

SERMs revisited: Can they improve menopausal care?
https://www.mdedge.com/obgyn/article/253626/menopause/serms-revisited-can-they-improve-menopausal-care
Steven R. Goldstein, MD, NCMP, CCD

Apr 8th, 2022 - Selective estrogen receptor modulators (SERMs) are unique synthetic compounds that bind to the estrogen receptor and initiate either estrogenic agonistic or antagonistic activity, depending on the confirmational change they produce on binding to t.

Patients With Multiple Myeloma Face Some Unique Sexual Challenges
https://www.medscape.com/viewarticle/970101

Mar 10th, 2022 - The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaway Patients with multiple myeloma face several unique sexual challenges. These challenges are not frequently discusse...

Dyspareunia: Keys to biopsychosocial evaluation and treatment planning
https://www.mdedge.com/familymedicine/article/252543/pain/dyspareunia-keys-biopsychosocial-evaluation-and-treatment
MDedge Family Medicine; Adrienne A. Williams, PhD

Mar 8th, 2022 - Dyspareunia is persistent or recurrent pain before, during, or after sexual contact and is not limited to cisgender individuals or vaginal intercourse. 1-3 With a prevalence as high as 45% in the United States,2-5 it is one of the most common compl.

Dr. Goetz on Adverse Events With Aromatase Inhibitors in Breast Cancer
https://www.onclive.com/view/dr-goetz-on-adverse-events-with-aromatase-inhibitors-in-breast-cancer

Oct 6th, 2021 - Matthew P. Goetz, MD, consultant, Division of Medical Oncology, Department of Oncology, Mayo Clinic, discusses adverse events (AEs) associated with aromatase inhibitors (AIs). Arthralgia, one of the main AEs of AIs, can be mild for some patients ...

Innovative therapies in gynecology: The evidence and your practice
https://www.mdedge.com/obgyn/article/245928/gynecology/innovative-therapies-gynecology-evidence-and-your-practice
Miles Murphy, MD, MSPH, Cecile Ferrando, MD, MPH et. al.

Sep 9th, 2021 - As more and more gynecologic therapies move to the outpatient setting, keeping up on the latest data regarding emerging options can be challenging. Furthermore, it can be difficult to justify purchasing expensive equipment for the office when a th.

see more →

Patient Education  4 results see all →